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Introduction 
Hepatitis A virus (HAV) is the most common 
cause of viral hepatitis. HAV is a small, non-
enveloped, single-stranded RNA virus from 
the Picornaviridae family. The risk of 
infection is universally distributed. The 
incidence of infection has a strong relation 
with sanitary and environmental conditions 
and the level of socioeconomic development. 
Hepatitis A has a high rate of endemicity in 
underdeveloped countries with poor 
sanitation. The virus has a fecal-oral 
transmission cycle and is transmitted through 
environmental contamination, mainly 
through drinking water and food. This form 
of transmission often requires direct contact 
between individuals.1-5 
Hepatitis A is an acute, usually, self-
limiting liver disease, but the course of the 
disease is not invariably benign. A dramatic 
complication of hepatitis A is acute liver 
failure. The patients at risk for this 
complication are elder patients with 
underlying liver disease or 
immunosuppressed patients. Hepatitis A in 
children usually has an asymptomatic course 
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Abstract 
Introduction: Hepatitis A is the most common viral hepatitis during childhood especially in 
developing countries. It is, usually, self-limiting, but may be associated with severe 
complications in some patients particularly those with comorbidities. This study was aimed to 
determine the seroprevalence of hepatitis A in 2-16 years old children in Tabriz, Iran. 
Methods: The study was a cross-sectional survey on all children who were referred to the 
clinic of Tabriz children hospital. For every subject, demographic data, including age, sex, 
method of sewage and waste disposal/type of water supply, history of blood transfusion and 
parent’s addiction were recorded. Immunoglobulin G (IgG) antibodies against hepatitis A 
virus (anti-HAV) were measured in sera by enzyme-linked immunosorbent assay. The 
association between seropositivity and demographic characteristics was studied. 
Results: This cross-sectional study was performed on 252 children aged 2-16 years in Tabriz 
city during 2012. Totally, 32.9% of children were sropositive for IgG antibody (anti-HAV) 
There was a significant difference in the history of blood product transfusion between two 
groups (P = 0.001). A total of 3% of case-patients had poor type of water supply. The 
discrepancy between two groups was statistically significant (P = 0.040). There was no 
significant statistic correlation in seroprevalence of hepatitis A relative to parent’s addiction  
(P = 0.480), age (P = 0.650) and sex (P = 0.890). 
Conclusion: According to this study, hepatitis A is prevalent in he pediatric population, and it 
must be considered in the approach to all susceptibl  cases of acute hepatitis. Considering the 
difficulties for the control of environmental sources, we need to have a protocol for routine 
vaccination of children in our country. 
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while in adults the clinical presentations are 
more common, thus in developed nations, 
the proportion of symptomatic cases is higher 
because infection is more likely in elder 
patients due to routine childhood vaccination 
coverage.6,7 Up to 70% of infected adults 
develop symptoms, including icterus. In 
contrast, only about 30% of children younger 
than 6 years become symptomatic, which are, 
usually, nonspecific and flu-like, without an 
apparent jaundice. The rising prevalence of 
HAV infection has led to an increase in the 
number of requests for HAV serologic tests.8,9 
This study was aimed to investigate the 
epidemiologic data on anti-HAV 
seroprevalence in Tabriz, Iran, in relation to 




This cross-sectional survey was performed on 
children who were referred to the clinic of 
Tabriz children hospital from April 2012 to 
April 2013. For every subject, the 
questionnaires, which included age, sex, 
method of sewage and waste disposal/type 
of water supply, blood product transfusion 
and parent’s addiction were filled by a fellow 
research by interviewing the parents. The 
association between seropositivity and 
demographic characteristics was studied. 
Written informed consents were obtained 
from all parents. A volume of 2 mL of the 
blood sample was taken from each case. 
Serum samples were stored at −20 °C. 
Hepatitis A immunoglobulin G (IgG) 
antibody was measured by an enzyme-linked 
immunosorbent assay test. The kit was 
produced by Italy DIA, PRO Company. 
Antibody levels more than the determined 
cut-off point were considered as positive. 
Data were analyzed with the SPSS software 
(version 17, SPSS Inc., Chicago, IL, USA). The 
prevalence of anti-hepatitis A antibodies was 
evaluated. Findings were described by  
mean ± standard deviation (SD) and the 
proportion, and the distribution was 
presented by SD. T-test, chi-squared test and 
Fisher’s exact test were used. P < 0.05 was 
considered as statistically significant. 
 
Results 
This cross-sectional study was carried out on 
2-16 years old children in Tabriz. The 
children were attended in the 
gastroenterology clinic of Tabriz children 
hospital. In total 252 children were studied. 
From 252 children, 135 children were boys 
(53.6%) and 377 (46.4%) were girls. The mean 
age was 8.1 ± 1.3 and 8.5 ± 0.5 years in HAV 
positive and negative groups respectively. 
The overall mean age was 8.4 ± 1.6 years. 
There was no significant relationship 
between seropositivity and age (P = 0.650). 
The overall rate of positive test results was 
32.9% for anti-HAV (total). 83 cases were 
seropositive, and 169 cases (67.1%) were 
seronegative and from the 83 seropositives, 
45 (54.2%) were boys, and 38 (45.7%) were 
girls. The rate of the anti-HAV positivity did 
not differ significantly between males and 
females (P = 0.890). 
A total of 3% of HAV positive patients 
compared with 1.6% of the control group had 
poor type of water supply/waste disposal. 
This discrepancy was statistically significant 
(P = 0.040). There was a significant difference 
in the history of blood product transfusion 
between two groups with P = 0.001. The 
relationship between parent’s addiction and 
seropositivity was not significant (P = 0.480). 
 
Discussion 
Hepatitis A is an acute, typically self-limiting 
liver disease and is one of the most common 
infectious diseases in the world. Hepatitis A 
causes reasonably little deaths, but it may be 
associated with a dramatic course resulting in 
acute liver failure and death. Presentation of 
disease is determined by the age of exposure, 
with a tendency to be asymptomatic or 
subclinical during childhood and 
symptomatic among adults. It has been 
reported that 70% of children < 6 years of age 
are asymptomatically infected or develop a 
mild self-limiting illness.1-5,10 
A systematic review in the United States 
reported following risk factors for the 
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transmission of HAV infection: sexual or 
household contact with a patient with 
hepatitis (25%), contact in a day-care center 
(15%), international travel to endemic areas 
(5%) and contaminated food or water-borne 
outbreak (5%). However, in about half of 
cases, no evident risk factor could be found.11 
Owing to a lack of comprehensive study in 
our country, determining the epidemiology 
of HAV is complicated, and there is limited 
data in this field. In our study, HAV 
seropositivity was investigated in 2-16 years 
old children, which was 32.9% in Tabriz city. 
A number of factors that influence the 
serology of HAV were evaluated in this 
survey. They included age, gender, method 
of waste disposal/type of water supply, 
blood product transfusion and parent’s 
addiction. Among these parameters, method 
of waste disposal/type of water supply and 
blood product transfusion had a significant 
relationship with the seropositivity of HAV 
(P = 0.040), P ≤ 0.001 respectively). The most 
frequently reported risk factor was poor 
condition of sewage and waste disposal and 
type of water supply. 
In the present study, case patients (HAV 
positive) and control subjects (HAV negative) 
did not differ with respect to demographic 
characteristics including age, sex, and 
parent’s addiction. In European developed 
countries, there is a decrease in prevalence of 
hepatitis A infection, especially among the 
younger age group, due to marked 
improvements in socioeconomic and hygiene 
situation and widespread coverage of 
vaccination. In a study by Pham et al. from 
Canada,12 the seroprevalence of HAV was 1% 
in children aged 8-13, 1-6% in ages 20-24, 10% 
in 25-29 and 17% in 30-39.13 
In a Korean study, the overall 
seropositivity rate of HAV was 51.06%. The 
male/female ratio for total anti-HAV 
seropositivity was not statistically significant 
(52.86% vs. 49.44%, P = 0.560). In another 
study from this country, the total rate of the 
anti-HAV positivity was 62.8%.9,14 
Some studies from our country have 
evaluated the epidemiology of HAV. In 
previous reports, the rate of HAV 
seropositivity was 8.09% and 44.3% in 
Isfahan15 and Zanjan in Iran16 pediatric 
patients respectively. There was no association 
between sex and positive antibody in the 
former study and between sex, age and 
seropositivity in the latter survey.15,16 
In a study by Taghavi et al. in Kashan, 
Iran, twenty-six out of 680 cases (3.9%) were 
seropositive for HAV antibody. The relation 
between seropositivity and sex was not 
statistically significant (P = 0.772).17 A 
significant discrepancy in the mean age 
among two seropositive and seronegative 
population was not reported (P = 0.215). The 
findings of our study are in accordance with 
those three studies. 
In another study from Shiraz in Iran, IgG 
antibody of hepatitis A was positive in 88.2% of 
individuals. In this study, the seroprevalence 
was significantly associated with poor water 
supply and older age (P = 0.001 and P = 0.010 
respectively). 79.3% of cases under 20 years and 
91.3% of subjects 20-30 years of age were 
seropositive. This rate was 99% for the cases 
more than 30 years of age.18 The seroprevalence 
is more higher in this study than present 
survey, but the association with studied factors 
is similar to our survey. 
We did not find any studies in the literature 
that reported results in terms of the effect of 
blood product transfusion and parent's 
addiction on the seroprevalence of HAV in 
children. The association between the history of 
transfusion and HAV seropositivity seems to 
be due to the small sample size of study; 
however it may be attributed to high rate of 
acquired HAV antibody transmitted in 
chronically transfused patients. The present 
study had a number of limitations; however it 
had public health implications and will add on 




Considering the controversial results in 
investigations evaluating the effect of risk 
factors on seroprevalence of HAV, it seems 
difficult to have a guideline for the handling 
of HAV infection. In order to evaluate the 
influence of each factor, cases should be 
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matched with controls in several 
characteristics. Well-structured studies with 
larger sample size are needed to determine 
the association of any parameter with 
seropositivity rate of HAV and guide health 
care workers to determine the HAV 
epidemiology and disease burden. With 
regards to the difficulties for the control of 
environmental sources, promoting hygiene 
and appropriate sanitation, we need a 
universal coverage for hepatitis A vaccination  
of children in our country. 
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